Case Study: Long COVID Fatigue in a 35-Year-Old Man — Mitochondrial Restoration Protocol with 12-Week Follow-Up

Illustrative composite — not a single patient. This case study is a teaching composite synthesised from anonymised patterns in the published clinical literature, Nutri-Link case-history references, and the Stewart Nutrition practitioner reference guide for deficiency assessment. It does not describe a specific identifiable patient seen by Codenutri Ltd or any single practitioner. Names, demographic specifics, and quoted dialogue are constructed for educational illustration. Always work with a registered clinician for individual care.

Key learning points

• Post-viral mitochondrial dysfunction is measurable via organic acids testing: reduced citric acid cycle intermediates, elevated lactate at rest, and depleted CoQ10 form a characteristic pattern in long COVID.
• Structured pacing with heart rate monitoring is the evidence-based alternative to graded exercise therapy (GET) for post-exertional malaise. The NICE 2021 guideline (NG206) explicitly recommends against GET for ME/CFS.
• Mitochondrial restoration requires a sequenced approach: reduce oxidative stress first (NAC, pacing), then supply substrates (CoQ10, D-ribose, nicotinamide riboside). Without the first step, supplements are consumed by ongoing damage.
• Low T3 syndrome in chronic illness is often reversible through selenium, zinc, and mitochondrial support — without thyroid hormone replacement.
• Outcomes are illustrative and reflect composite patterns. Individual responses vary depending on viral variant, symptom duration, co-morbidities, adherence, and practitioner oversight.

Patient presentation

James (composite), a 35-year-old architect and father of two from Oxford, presented with a 20‑month history of debilitating fatigue, post-exertional malaise (PEM), brain fog, orthostatic intolerance, and new-onset cold intolerance following SARS-CoV-2 infection (Omicron, August 2024). Conventional cardiology, respiratory, and rheumatology work-up was unremarkable. Graded exercise therapy and CBT had been trialled and were ineffective; GET worsened symptoms.

Baseline findings included:

• Profound fatigue (Chalder Fatigue Scale 8/10) with clear PEM after modest exertion.
• Visible muscle wasting of upper arms and quadriceps.
• Dry, rough skin and mild follicular hyperkeratosis (suggestive of essential fatty acid and vitamin C insufficiency).
• Angular cheilitis and brittle, ridged nails (functional iron and B2 insufficiency).
• Brain fog, word-finding difficulty, short-term memory lapses, and orthostatic dizziness.
• Conventional labs within NHS reference ranges but functionally suboptimal ferritin (42 µg/L), vitamin D (48 nmol/L), B12 (298 pg/mL), and TSH 2.8 mIU/L without T3/T4.

Functional Health Matrix and Wheel of Life

The Functional Health Matrix (FHM) revealed a characteristic “hourglass” pattern:

• Energy Production: 1/5 — core pathological node with severe fatigue, PEM, low CoQ10, low citric acid cycle intermediates, and elevated lactate.
• Communication: 1/5 — HPA axis flattening, low T3 syndrome, cognitive dysfunction.
• Defence & Repair: 2/5 — persistent post-viral symptoms, mildly elevated CRP, shingles episode.
• Other nodes (structural integrity, transport, biotransformation, assimilation) were moderately impaired.

Total initial FHM score: 15/35 (moderate-to-severe dysfunction centred on energy and communication).

Wheel of Life scoring highlighted crisis-level impairment in:

• Movement & Exercise: 1/10 — <2,000 steps/day, frequent PEM, failed couch-to-5K attempt.
• Sleep & Recovery: 2/10 — unrefreshing sleep, frequent awakenings, “tired but wired” pattern.

Total initial Wheel of Life score: 32/80.

Functional testing

Organic Acids Test (OAT)

Pattern consistent with acquired mitochondrial dysfunction:

• Multiple low citric acid cycle intermediates (citrate, cis-aconitate, succinate, alpha-ketoglutarate, malate at ~30–60% of expected values).
• Elevated lactate (52 µg/mg creatinine) and pyruvate, indicating a shift toward anaerobic metabolism at rest.
• Elevated beta-hydroxybutyrate and 8-OHdG, reflecting impaired carbohydrate utilisation and oxidative DNA damage.

Nutritional assessment

• Low plasma CoQ10 (0.48 µg/mL; optimal >0.8).
• Low RBC magnesium (4.2 mg/dL; optimal 5.5–6.8).
• Functional insufficiency of ferritin, B12, folate, vitamin D, zinc, selenium.
• Low RBC glutathione (768 µmol/L; optimal >900).

Thyroid and HPA axis

• Low T3 syndrome / non-thyroidal illness: free T3 3.8 pmol/L (low), elevated reverse T3, low T3/rT3 ratio (12.7; optimal >20) with TSH 2.8 mIU/L.
• Flattened salivary cortisol curve: low morning output, relatively elevated evening cortisol.

These data supported a coherent narrative of post-viral mitochondrial impairment with downstream endocrine and redox disruption.

Intervention protocol (12 weeks)

Phase 1 (Weeks 1–4): Stabilise and pace

Core strategy:

• Structured pacing with heart rate monitoring — ceiling set at (220 − age) × 0.55 ≈ 101 bpm. All activity kept below this threshold; any breach prompted immediate rest. GET was explicitly avoided in line with NICE NG206.

Key supplements:

• CoQ10 (ubiquinol) 200 mg twice daily.
• N-acetylcysteine (NAC) 600 mg twice daily.
• Magnesium glycinate 200 mg twice daily.
• Vitamin D3 4,000 IU daily with K2 (100 µg MK-7).

Aim: reduce oxidative stress, restore glutathione, and support ATP synthesis while preventing PEM via pacing.

Phase 2 (Weeks 5–8): Restore mitochondrial function

Building on Phase 1, mitochondrial substrates and cofactors were added:

• Nicotinamide riboside (NR) titrated to 600 mg daily.
• D-ribose 5 g twice daily.
• Acetyl-L-carnitine 1,000 mg daily.
• R-lipoic acid 200 mg daily.

Dietary changes:

• Protein intake increased to ~1.6 g/kg (≈120 g/day) to support muscle rebuilding and mitochondrial enzymes.
• Mediterranean-style, anti-inflammatory pattern emphasising polyphenols and healthy fats.

Phase 3 (Weeks 9–12): Rebalance and rebuild

Pacing progression and movement:

• Heart rate ceiling cautiously raised to 60% of age-predicted maximum (~110 bpm).
• Walking increased by ≤10% per week, with strict monitoring for PEM.

Sleep and stress:

• Fixed sleep window (22:30–07:00), 45-minute wind-down, evening magnesium, guided body-scan.
• Daily box-breathing (4-4-4-4) and morning light exposure.

Thyroid support:

• Selenium 200 µg (selenium methionine) and zinc 30 mg (picolinate) to support deiodinase-mediated T4→T3 conversion, avoiding thyroid hormone replacement.

Psychosocial interventions:

• Gentle re-engagement with valued roles (family, work, running club for social contact only).
• Explicit permission to rest without guilt.

Outcomes at 12 weeks

Symptom changes

• Fatigue: Chalder score improved from 8/10 to 2/10. PEM episodes decreased from 3–4/week to one minor episode every 2–3 weeks, resolving within hours. Daily steps increased to 8,000–10,000 without crashes.
• Cognition: Brain fog and word-finding difficulty resolved; short-term memory and processing speed normalised for work demands.
• Sleep: Sleep latency reduced to ~20 minutes, nocturnal awakenings decreased, and subjective restfulness improved (PSQI from 14 to 6).
• Mood: Marked reduction in health-related anxiety and improved sense of control.

Repeat testing

OAT:

• Citric acid cycle intermediates (e.g., citrate 315 µmol/mmol creatinine) normalised.
• Lactate decreased to 28 µg/mg creatinine (below anaerobic threshold).
• 8-OHdG fell to 3.1 ng/mg creatinine (~47% reduction in oxidative DNA damage).

Nutritional markers:

• Ferritin 78 µg/L; B12 612 pg/mL; RBC magnesium 5.9 mg/dL; CoQ10 1.2 µg/mL; vitamin D 112 nmol/L; RBC glutathione 1,024 µmol/L — all within functional optimal ranges.

Thyroid and cortisol:

• TSH 1.6 mIU/L; free T3 5.1 pmol/L; T3/rT3 ratio 24.8 — low T3 syndrome resolved without thyroid hormone.
• Morning cortisol normalised with restoration of a healthy diurnal curve.

Functional Health Matrix and Wheel of Life

• FHM total improved from 15/35 to 28/35. Largest gains were in Energy Production (+3) and Communication (+3), converting the “hourglass” pattern into a near-circular profile.
• Wheel of Life total improved from 32/80 to 57/80, with major improvements in Sleep & Recovery (+5) and Movement & Exercise (+5), achieved via pacing rather than GET.

Maintenance plan

• CoQ10 200 mg daily, magnesium glycinate 200 mg daily, vitamin D3 2,000 IU daily, D-ribose 5 g as needed on higher-demand days.
• Continued heart-rate-informed pacing and gradual, symptom-led activity increases.
• Planned repeat OAT and nutritional panels at 6 months; stool microbiome analysis to assess residual dysbiosis.

Transferable learning points

1. “Normal” bloods can mask functional crises. Values within population reference ranges (e.g., ferritin 42 µg/L, B12 298 pg/mL, TSH 2.8 mIU/L) can be inadequate in the context of post-viral mitochondrial stress.
2. Pacing is not graded exercise. GET exacerbated PEM, whereas structured pacing with heart rate monitoring reduced crashes and enabled safe activity gains, aligning with NICE NG206.
3. Sequence matters in mitochondrial care. Reducing oxidative stress (NAC, pacing) before adding substrates (CoQ10, D-ribose, NR) prevents ongoing damage from consuming new inputs.
4. Low T3 syndrome is often reversible. In this composite, selenium, zinc, mitochondrial support, and sleep restoration normalised T3 and T3/rT3 without thyroid hormone.

When to seek professional support

Persistent fatigue, brain fog, or exercise intolerance after infection warrants assessment by a clinician experienced in post-viral and mitochondrial medicine. Emergency symptoms require urgent medical care via local emergency services. Emotional distress should be directed to appropriate crisis support services.

Practitioner summary

• Use OAT to assess citric acid cycle function, resting lactate, and oxidative stress in post-viral fatigue.
• Measure plasma CoQ10, RBC magnesium, glutathione, selenium, and zinc alongside standard panels.
• Request expanded thyroid testing (free T3, free T4, reverse T3, T3/rT3 ratio) rather than relying on TSH alone.
• Implement structured pacing with HR monitoring before any exercise prescription; avoid GET in patients with PEM.
• Sequence mitochondrial restoration: Phase 1 (NAC, CoQ10, magnesium, vitamin D, pacing) then Phase 2 (NR, D-ribose, acetyl-L-carnitine, R-lipoic acid) and Phase 3 (thyroid cofactor support, sleep, stress, and movement retraining).
• Increase protein intake to ~1.6 g/kg to support muscle and mitochondrial recovery.
• Reassess clinically and biochemically at 12 weeks and 6 months to guide maintenance.

This composite case is for educational purposes only and does not constitute individual medical advice.

For practitioners: see these tools in action

The Functional Health Matrix and Wheel of Life visualisations shown in this case study are native tools inside the EPINUTRI practitioner platform. They generate automatically from patient intake data and update in real time as clinical outcomes are recorded. Practitioners using EPINUTRI can view baseline-to-follow-up comparisons, identify priority nodes at a glance, and share visual progress reports with patients during consultations.

Explore the EPINUTRI practitioner platform | Book a discovery call